What Does It Cost to Create a Cancer Drug? Less Than You'd Think – New York Times
New York Times |
What Does It Cost to Create a Cancer Drug? Less Than You’d Think
New York Times A researcher at Pharmacyclics in Sunnyvale, Calif., which developed the cancer drug ibrutinib. The drug was sold for $21 billion. Credit Jim Wilson/The New York Times. What does it really cost to bring a drug to market? The question is central to the … What Does ROI Say About Drug Pricing? A new study undermines Big Pharma’s justification for charging high drug prices Cancer drug revenue substantially higher than R&D spending |
View original article
Author:
Powered by WPeMatico
Health Topic Contributor
Editors and curators bringing you the latest and most impactful health news. Truly objective, we print links to stories and studies that may contradict one another. If you're searching for news on health studies, alternative health modalities, facts on modern allopathic medicine, and more, we're you're team bringing you the stories and facts that matter.